Francis Laurencio - 11 Mar 2026 Form 4 Insider Report for Atomera Inc (ATOM)

Role
CFO
Signature
By: Mindi Zimmer, as Attorney-in-Fact For: Francis Laurencio
Issuer symbol
ATOM
Transactions as of
11 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 20:05:04 UTC
Previous filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Laurencio Francis CFO C/O ATOMERA, INC., 750 UNIVERSITY AVENUE, SUITE 280, LOS GATOS By: Mindi Zimmer, as Attorney-in-Fact For: Francis Laurencio 13 Mar 2026 0001680612

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOM Performance Stock Option (right to buy) Award +78,888 $0.000000* 78,888 11 Mar 2026 Common Stock 78,888 $5.10 Direct F1
transaction ATOM Performance Stock Option (right to buy) Award +39,444 $0.000000* 39,444 11 Mar 2026 Common Stock 39,444 $5.10 Direct F2
transaction ATOM Performance Stock Option (right to buy) Award +39,444 $0.000000* 39,444 11 Mar 2026 Common Stock 39,444 $5.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Francis Laurencio is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $20.00. In the event the $20.00 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
F2 Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $7.50. In the event the $7.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.
F3 Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $12.50. In the event the $12.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.